Advertisement
Screener

BRILLIANT N.E.V. CORP. Research and Development Expense

BRILLIANT N.E.V. CORP. Research and Development Expense

BRILLIANT N.E.V. CORP. reported Research and Development Expense of $0 for the 3-month period ending 2024-04-30, per its 10-Q filed 2026-04-08.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-08

  • BRILLIANT N.E.V. CORP. research and development expense for the quarter ending 2024-04-30 was $0.00, a 100.00% decline year-over-year.
  • BRILLIANT N.E.V. CORP. research and development expense for the quarter ending 2024-01-31 was $0.00, a 100.00% decline year-over-year.
  • BRILLIANT N.E.V. CORP. research and development expense for the quarter ending 2023-10-31 was $0.00, a 100.00% decline year-over-year.
  • BRILLIANT N.E.V. CORP. research and development expense for the quarter ending 2023-07-31 was -$317.00, a 100.58% decline year-over-year.
  • BRILLIANT N.E.V. CORP. research and development expense for fiscal 2023 was $53.16K, a 79.46% decline from fiscal 2022.
  • BRILLIANT N.E.V. CORP. research and development expense for fiscal 2022 was $258.76K, a 21.18% increase from fiscal 2021.
  • BRILLIANT N.E.V. CORP. research and development expense for fiscal 2021 was $213.53K.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2024-04-30$0.00
10-Q · filed 2026-04-08
$0.00
derived: sum of 2 quarters · filed 2026-04-08
$0.00
10-Q · filed 2026-04-08
-$317.00
derived: sum of 4 quarters · filed 2026-04-08
2024-01-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-18
$0.00
10-Q · filed 2024-03-18
-$317.00
derived: sum of 3 quarters · filed 2024-03-18
$11.63K
derived: sum of 4 quarters · filed 2026-04-08
2023-10-31$0.00
10-Q · filed 2023-12-13
-$317.00
derived: sum of 2 quarters · filed 2023-12-13
$11.63K
derived: sum of 3 quarters · filed 2026-04-08
$26.73K
derived: sum of 4 quarters · filed 2026-04-08
2023-07-31-$317.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-14
$11.63K
derived: sum of 2 quarters · filed 2026-04-08
$26.73K
derived: sum of 3 quarters · filed 2026-04-08
$53.16K
10-K · filed 2023-11-14
2023-04-30$11.94K
10-Q · filed 2026-04-08
$27.05K
derived: sum of 2 quarters · filed 2026-04-08
$53.48K
10-Q · filed 2026-04-08
$108.00K
derived: sum of 4 quarters · filed 2026-04-08
2023-01-31$15.11K
10-Q · filed 2023-03-16
$41.53K
10-Q · filed 2024-03-18
$96.05K
derived: sum of 3 quarters · filed 2023-12-13
$159.80K
derived: sum of 4 quarters · filed 2023-12-13
2022-10-31$26.43K
10-Q · filed 2023-12-13
$80.94K
derived: sum of 2 quarters · filed 2023-12-13
$144.69K
derived: sum of 3 quarters · filed 2023-12-13
$214.71K
derived: sum of 4 quarters · filed 2023-12-13
2022-07-31$54.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-14
$118.26K
derived: sum of 2 quarters · filed 2023-11-14
$188.28K
derived: sum of 3 quarters · filed 2023-11-14
$258.76K
10-K · filed 2023-11-14
2022-04-30$63.74K
10-Q · filed 2023-06-20
$133.76K
derived: sum of 2 quarters · filed 2023-06-20
$204.25K
10-Q · filed 2023-06-20
$377.16K
derived: sum of 4 quarters · filed 2023-06-20
2022-01-31$70.02K
10-Q · filed 2023-03-16
$140.50K
10-Q · filed 2023-03-16
$313.41K
derived: sum of 3 quarters · filed 2023-03-16
$314.50K
derived: sum of 4 quarters · filed 2023-03-16
2021-10-31$70.48K
10-Q · filed 2022-12-15
$243.39K
derived: sum of 2 quarters · filed 2022-12-15
$244.49K
derived: sum of 3 quarters · filed 2022-12-15
$244.49K
derived: sum of 4 quarters · filed 2022-12-15
2021-07-31$172.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31
$174.00K
derived: sum of 2 quarters · filed 2022-10-31
$174.00K
derived: sum of 3 quarters · filed 2022-10-31
$213.53K
10-K · filed 2022-10-31
2021-04-30$1.09K
10-Q · filed 2022-06-14
$1.09K
derived: sum of 2 quarters · filed 2022-06-14
$40.62K
10-Q · filed 2022-06-14
2021-01-31$0.00
10-Q · filed 2022-03-15
$39.53K
10-Q · filed 2022-03-15
2020-10-31$39.53K
10-Q · filed 2021-12-15